Compile Data Set for Download or QSAR
maximum 50k data
Found 39 with Last Name = 'olsson' and Initial = 'h'
TargetMAP kinase-activated protein kinase 2(Homo sapiens (Human))
Astrazeneca R & D Lund

Curated by ChEMBL
LigandPNGBDBM50323635(6-(4-chlorophenyl)-N-(4-(4-methylpiperazin-1-yl)ph...)
Affinity DataKi:  96nMAssay Description:Competitive inhibition of MK2 ATP-binding siteMore data for this Ligand-Target Pair
In DepthDetails ArticlePubMed
TargetMAP kinase-activated protein kinase 2(Homo sapiens (Human))
Astrazeneca R & D Lund

Curated by ChEMBL
LigandPNGBDBM50323635(6-(4-chlorophenyl)-N-(4-(4-methylpiperazin-1-yl)ph...)
Affinity DataKi:  310nMAssay Description:Uncompetitive inhibition of MK2 ATP-binding siteMore data for this Ligand-Target Pair
In DepthDetails ArticlePubMed
TargetMAP kinase-activated protein kinase 2(Homo sapiens (Human))
Astrazeneca R & D Lund

Curated by ChEMBL
LigandPNGBDBM50323635(6-(4-chlorophenyl)-N-(4-(4-methylpiperazin-1-yl)ph...)
Affinity DataKi:  320nMAssay Description:Mixed inhibition of MK2 ATP-binding siteMore data for this Ligand-Target Pair
In DepthDetails ArticlePubMed
TargetMAP kinase-activated protein kinase 2(Homo sapiens (Human))
Astrazeneca R & D Lund

Curated by ChEMBL
LigandPNGBDBM50323635(6-(4-chlorophenyl)-N-(4-(4-methylpiperazin-1-yl)ph...)
Affinity DataKi:  480nMAssay Description:Noncompetitive inhibition of MK2 ATP-binding siteMore data for this Ligand-Target Pair
In DepthDetails ArticlePubMed
TargetMAP kinase-activated protein kinase 2(Homo sapiens (Human))
Astrazeneca R & D Lund

Curated by ChEMBL
LigandPNGBDBM50323634(6-(4-bromophenyl)-N-(4-(4-methylpiperazin-1-yl)phe...)
Affinity DataIC50:  400nMAssay Description:Inhibition of MK2 assessed as inhibition of [33P]ATP incorporation in to substrate after 30 mins by scintillation countingMore data for this Ligand-Target Pair
In DepthDetails ArticlePubMed
TargetMAP kinase-activated protein kinase 2(Homo sapiens (Human))
Astrazeneca R & D Lund

Curated by ChEMBL
LigandPNGBDBM50323635(6-(4-chlorophenyl)-N-(4-(4-methylpiperazin-1-yl)ph...)
Affinity DataIC50:  600nMAssay Description:Inhibition of MK2 assessed as inhibition of [33P]ATP incorporation in to substrate after 30 mins by scintillation countingMore data for this Ligand-Target Pair
In DepthDetails ArticlePubMed
TargetMAP kinase-activated protein kinase 2(Homo sapiens (Human))
Astrazeneca R & D Lund

Curated by ChEMBL
LigandPNGBDBM50323645(CHEMBL1209120 | N-(4-(4-methylpiperazin-1-yl)pheny...)
Affinity DataIC50:  700nMAssay Description:Inhibition of MK2 assessed as inhibition of [33P]ATP incorporation in to substrate after 30 mins by scintillation countingMore data for this Ligand-Target Pair
In DepthDetails ArticlePubMed
TargetMAP kinase-activated protein kinase 2(Homo sapiens (Human))
Astrazeneca R & D Lund

Curated by ChEMBL
LigandPNGBDBM50323636(6-(4-fluorophenyl)-N-(4-(4-methylpiperazin-1-yl)ph...)
Affinity DataIC50:  700nMAssay Description:Inhibition of MK2 assessed as inhibition of [33P]ATP incorporation in to substrate after 30 mins by scintillation countingMore data for this Ligand-Target Pair
In DepthDetails ArticlePubMed
TargetMAP kinase-activated protein kinase 2(Homo sapiens (Human))
Astrazeneca R & D Lund

Curated by ChEMBL
LigandPNGBDBM50323646(CHEMBL1209121 | N-(4-(4-methylpiperazin-1-yl)pheny...)
Affinity DataIC50:  800nMAssay Description:Inhibition of MK2 assessed as inhibition of [33P]ATP incorporation in to substrate after 30 mins by scintillation countingMore data for this Ligand-Target Pair
In DepthDetails ArticlePubMed
TargetMAP kinase-activated protein kinase 2(Homo sapiens (Human))
Astrazeneca R & D Lund

Curated by ChEMBL
LigandPNGBDBM50323644(CHEMBL1209119 | N-(4-(4-methylpiperazin-1-yl)pheny...)
Affinity DataIC50:  1.40E+3nMAssay Description:Inhibition of MK2 assessed as inhibition of [33P]ATP incorporation in to substrate after 30 mins by scintillation countingMore data for this Ligand-Target Pair
In DepthDetails ArticlePubMed
TargetMAP kinase-activated protein kinase 2(Homo sapiens (Human))
Astrazeneca R & D Lund

Curated by ChEMBL
LigandPNGBDBM50323647(CHEMBL1209122 | N-(4-(4-methylpiperazin-1-yl)pheny...)
Affinity DataIC50:  1.40E+3nMAssay Description:Inhibition of MK2 assessed as inhibition of [33P]ATP incorporation in to substrate after 30 mins by scintillation countingMore data for this Ligand-Target Pair
In DepthDetails ArticlePubMed
TargetMAP kinase-activated protein kinase 2(Homo sapiens (Human))
Astrazeneca R & D Lund

Curated by ChEMBL
LigandPNGBDBM50323640(CHEMBL1209066 | N-(4-(4-methylpiperazin-1-yl)pheny...)
Affinity DataIC50:  1.50E+3nMAssay Description:Inhibition of MK2 assessed as inhibition of [33P]ATP incorporation in to substrate after 30 mins by scintillation countingMore data for this Ligand-Target Pair
In DepthDetails ArticlePubMed
TargetMAP kinase-activated protein kinase 2(Homo sapiens (Human))
Astrazeneca R & D Lund

Curated by ChEMBL
LigandPNGBDBM50323643(4-(4-(4-(4-methylpiperazin-1-yl)phenylamino)quinol...)
Affinity DataIC50:  1.80E+3nMAssay Description:Inhibition of MK2 assessed as inhibition of [33P]ATP incorporation in to substrate after 30 mins by scintillation countingMore data for this Ligand-Target Pair
In DepthDetails ArticlePubMed
TargetMAP kinase-activated protein kinase 2(Homo sapiens (Human))
Astrazeneca R & D Lund

Curated by ChEMBL
LigandPNGBDBM50323641(6-(3-chlorophenyl)-N-(4-(4-methylpiperazin-1-yl)ph...)
Affinity DataIC50:  2.60E+3nMAssay Description:Inhibition of MK2 assessed as inhibition of [33P]ATP incorporation in to substrate after 30 mins by scintillation countingMore data for this Ligand-Target Pair
In DepthDetails ArticlePubMed
TargetMAP kinase-activated protein kinase 2(Homo sapiens (Human))
Astrazeneca R & D Lund

Curated by ChEMBL
LigandPNGBDBM50323630(CHEMBL549224 | N-(4-(4-methylpiperazin-1-yl)phenyl...)
Affinity DataIC50:  5.20E+3nMAssay Description:Inhibition of MK2 assessed as inhibition of [33P]ATP incorporation in to substrate after 30 mins by scintillation countingMore data for this Ligand-Target Pair
In DepthDetails ArticlePubMed
TargetMAP kinase-activated protein kinase 2(Homo sapiens (Human))
Astrazeneca R & D Lund

Curated by ChEMBL
LigandPNGBDBM50323642(6-(3-methoxyphenyl)-N-(4-(4-methylpiperazin-1-yl)p...)
Affinity DataIC50:  8.00E+3nMAssay Description:Inhibition of MK2 assessed as inhibition of [33P]ATP incorporation in to substrate after 30 mins by scintillation countingMore data for this Ligand-Target Pair
In DepthDetails ArticlePubMed
TargetMAP kinase-activated protein kinase 2(Homo sapiens (Human))
Astrazeneca R & D Lund

Curated by ChEMBL
LigandPNGBDBM50323638(CHEMBL1209010 | N-(4-(4-methylpiperazin-1-yl)pheny...)
Affinity DataIC50:  9.00E+3nMAssay Description:Inhibition of MK2 assessed as inhibition of [33P]ATP incorporation in to substrate after 30 mins by scintillation countingMore data for this Ligand-Target Pair
In DepthDetails ArticlePubMed
TargetMAP kinase-activated protein kinase 2(Homo sapiens (Human))
Astrazeneca R & D Lund

Curated by ChEMBL
LigandPNGBDBM50323618(4-(6-(4-chlorophenyl)quinolin-4-ylamino)benzoic ac...)
Affinity DataIC50:  1.20E+4nMAssay Description:Inhibition of MK2 assessed as inhibition of [33P]ATP incorporation in to substrate after 30 mins by scintillation countingMore data for this Ligand-Target Pair
In DepthDetails ArticlePubMed
TargetMAP kinase-activated protein kinase 2(Homo sapiens (Human))
Astrazeneca R & D Lund

Curated by ChEMBL
LigandPNGBDBM50323639(6-(3-aminophenyl)-N-(4-(4-methylpiperazin-1-yl)phe...)
Affinity DataIC50:  1.40E+4nMAssay Description:Inhibition of MK2 assessed as inhibition of [33P]ATP incorporation in to substrate after 30 mins by scintillation countingMore data for this Ligand-Target Pair
In DepthDetails ArticlePubMed
TargetMAP kinase-activated protein kinase 2(Homo sapiens (Human))
Astrazeneca R & D Lund

Curated by ChEMBL
LigandPNGBDBM50323623((4-(6-(4-chlorophenyl)quinolin-4-ylamino)phenyl)(4...)
Affinity DataIC50:  1.50E+4nMAssay Description:Inhibition of MK2 assessed as inhibition of [33P]ATP incorporation in to substrate after 30 mins by scintillation countingMore data for this Ligand-Target Pair
In DepthDetails ArticlePubMed
TargetMAP kinase-activated protein kinase 2(Homo sapiens (Human))
Astrazeneca R & D Lund

Curated by ChEMBL
LigandPNGBDBM50323615(2-(4-(6-phenylquinolin-4-ylamino)phenyl)ethanol | ...)
Affinity DataIC50:  2.20E+4nMAssay Description:Inhibition of MK2 assessed as inhibition of [33P]ATP incorporation in to substrate after 30 mins by scintillation countingMore data for this Ligand-Target Pair
In DepthDetails ArticlePubMed
TargetMAP kinase-activated protein kinase 2(Homo sapiens (Human))
Astrazeneca R & D Lund

Curated by ChEMBL
LigandPNGBDBM50323619(4-(6-(4-chlorophenyl)quinolin-4-ylamino)phenol | C...)
Affinity DataIC50:  2.30E+4nMAssay Description:Inhibition of MK2 assessed as inhibition of [33P]ATP incorporation in to substrate after 30 mins by scintillation countingMore data for this Ligand-Target Pair
In DepthDetails ArticlePubMed
TargetMAP kinase-activated protein kinase 2(Homo sapiens (Human))
Astrazeneca R & D Lund

Curated by ChEMBL
LigandPNGBDBM50323620(6-(4-chlorophenyl)-N-(4-morpholinophenyl)quinolin-...)
Affinity DataIC50:  2.40E+4nMAssay Description:Inhibition of MK2 assessed as inhibition of [33P]ATP incorporation in to substrate after 30 mins by scintillation countingMore data for this Ligand-Target Pair
In DepthDetails ArticlePubMed
TargetMAP kinase-activated protein kinase 2(Homo sapiens (Human))
Astrazeneca R & D Lund

Curated by ChEMBL
LigandPNGBDBM50323625(4-(6-p-tolylquinolin-4-ylamino)phenol | CHEMBL1208...)
Affinity DataIC50:  2.50E+4nMAssay Description:Inhibition of MK2 assessed as inhibition of [33P]ATP incorporation in to substrate after 30 mins by scintillation countingMore data for this Ligand-Target Pair
In DepthDetails ArticlePubMed
TargetMAP kinase-activated protein kinase 2(Homo sapiens (Human))
Astrazeneca R & D Lund

Curated by ChEMBL
LigandPNGBDBM50323631(CHEMBL1208888 | N-(4-(4-methylpiperazin-1-yl)pheny...)
Affinity DataIC50:  2.60E+4nMAssay Description:Inhibition of MK2 assessed as inhibition of [33P]ATP incorporation in to substrate after 30 mins by scintillation countingMore data for this Ligand-Target Pair
In DepthDetails ArticlePubMed
TargetMAP kinase-activated protein kinase 2(Homo sapiens (Human))
Astrazeneca R & D Lund

Curated by ChEMBL
LigandPNGBDBM50323622(4-(6-(4-chlorophenyl)quinolin-4-ylamino)benzonitri...)
Affinity DataIC50:  2.70E+4nMAssay Description:Inhibition of MK2 assessed as inhibition of [33P]ATP incorporation in to substrate after 30 mins by scintillation countingMore data for this Ligand-Target Pair
In DepthDetails ArticlePubMed
TargetMAP kinase-activated protein kinase 2(Homo sapiens (Human))
Astrazeneca R & D Lund

Curated by ChEMBL
LigandPNGBDBM50323626(4-(6-p-tolylquinolin-4-ylamino)benzonitrile | CHEM...)
Affinity DataIC50:  2.70E+4nMAssay Description:Inhibition of MK2 assessed as inhibition of [33P]ATP incorporation in to substrate after 30 mins by scintillation countingMore data for this Ligand-Target Pair
In DepthDetails ArticlePubMed
TargetMAP kinase-activated protein kinase 2(Homo sapiens (Human))
Astrazeneca R & D Lund

Curated by ChEMBL
LigandPNGBDBM50323621(2-(4-(6-(4-chlorophenyl)quinolin-4-ylamino)phenyl)...)
Affinity DataIC50:  2.90E+4nMAssay Description:Inhibition of MK2 assessed as inhibition of [33P]ATP incorporation in to substrate after 30 mins by scintillation countingMore data for this Ligand-Target Pair
In DepthDetails ArticlePubMed
TargetMAP kinase-activated protein kinase 2(Homo sapiens (Human))
Astrazeneca R & D Lund

Curated by ChEMBL
LigandPNGBDBM50323624(4-chloro-2-(6-p-tolylquinolin-4-ylamino)phenol | C...)
Affinity DataIC50:  3.30E+4nMAssay Description:Inhibition of MK2 assessed as inhibition of [33P]ATP incorporation in to substrate after 30 mins by scintillation countingMore data for this Ligand-Target Pair
In DepthDetails ArticlePubMed
TargetMAP kinase-activated protein kinase 2(Homo sapiens (Human))
Astrazeneca R & D Lund

Curated by ChEMBL
LigandPNGBDBM50323627(CHEMBL1208885 | N-(2,3-dimethylphenyl)-6-p-tolylqu...)
Affinity DataIC50:  3.50E+4nMAssay Description:Inhibition of MK2 assessed as inhibition of [33P]ATP incorporation in to substrate after 30 mins by scintillation countingMore data for this Ligand-Target Pair
In DepthDetails ArticlePubMed
TargetMAP kinase-activated protein kinase 2(Homo sapiens (Human))
Astrazeneca R & D Lund

Curated by ChEMBL
LigandPNGBDBM50323616(CHEMBL1209752 | N-(4-ethylphenyl)-6-phenylquinolin...)
Affinity DataIC50:  4.10E+4nMAssay Description:Inhibition of MK2 assessed as inhibition of [33P]ATP incorporation in to substrate after 30 mins by scintillation countingMore data for this Ligand-Target Pair
In DepthDetails ArticlePubMed
TargetMAP kinase-activated protein kinase 2(Homo sapiens (Human))
Astrazeneca R & D Lund

Curated by ChEMBL
LigandPNGBDBM50323628(4-chloro-2-(6-phenylquinolin-4-ylamino)phenol | CH...)
Affinity DataIC50:  4.30E+4nMAssay Description:Inhibition of MK2 assessed as inhibition of [33P]ATP incorporation in to substrate after 30 mins by scintillation countingMore data for this Ligand-Target Pair
In DepthDetails ArticlePubMed
TargetMAP kinase-activated protein kinase 2(Homo sapiens (Human))
Astrazeneca R & D Lund

Curated by ChEMBL
LigandPNGBDBM50323617(CHEMBL1209832 | N-(4-morpholinophenyl)-6-phenylqui...)
Affinity DataIC50:  1.20E+5nMAssay Description:Inhibition of MK2 assessed as inhibition of [33P]ATP incorporation in to substrate after 30 mins by scintillation countingMore data for this Ligand-Target Pair
In DepthDetails ArticlePubMed
TargetMAP kinase-activated protein kinase 2(Homo sapiens (Human))
Astrazeneca R & D Lund

Curated by ChEMBL
LigandPNGBDBM50323629(CHEMBL1208887 | N-(4-chloro-2-fluorophenyl)-6-(4-c...)
Affinity DataIC50:  1.21E+5nMAssay Description:Inhibition of MK2 assessed as inhibition of [33P]ATP incorporation in to substrate after 30 mins by scintillation countingMore data for this Ligand-Target Pair
In DepthDetails ArticlePubMed
TargetMAP kinase-activated protein kinase 2(Homo sapiens (Human))
Astrazeneca R & D Lund

Curated by ChEMBL
LigandPNGBDBM50323614(CHEMBL1209750 | N,6-diphenylquinolin-4-amine)
Affinity DataIC50: >2.00E+5nMAssay Description:Inhibition of MK2 assessed as inhibition of [33P]ATP incorporation in to substrate after 30 mins by scintillation countingMore data for this Ligand-Target Pair
In DepthDetails ArticlePubMed
TargetMAP kinase-activated protein kinase 2(Homo sapiens (Human))
Astrazeneca R & D Lund

Curated by ChEMBL
LigandPNGBDBM50323637(4-(4-(4-(4-methylpiperazin-1-yl)phenylamino)quinol...)
Affinity DataIC50: >2.00E+5nMAssay Description:Inhibition of MK2 assessed as inhibition of [33P]ATP incorporation in to substrate after 30 mins by scintillation countingMore data for this Ligand-Target Pair
In DepthDetails ArticlePubMed
TargetMAP kinase-activated protein kinase 2(Homo sapiens (Human))
Astrazeneca R & D Lund

Curated by ChEMBL
LigandPNGBDBM50323633(CHEMBL1208949 | N-(4-(4-methylpiperazin-1-yl)pheny...)
Affinity DataIC50: >2.00E+5nMAssay Description:Inhibition of MK2 assessed as inhibition of [33P]ATP incorporation in to substrate after 30 mins by scintillation countingMore data for this Ligand-Target Pair
In DepthDetails ArticlePubMed
TargetMAP kinase-activated protein kinase 2(Homo sapiens (Human))
Astrazeneca R & D Lund

Curated by ChEMBL
LigandPNGBDBM50323632(6-bromo-N-(4-(4-methylpiperazin-1-yl)phenyl)quinol...)
Affinity DataIC50: >2.00E+5nMAssay Description:Inhibition of MK2 assessed as inhibition of [33P]ATP incorporation in to substrate after 30 mins by scintillation countingMore data for this Ligand-Target Pair
In DepthDetails ArticlePubMed
TargetMAP kinase-activated protein kinase 2(Homo sapiens (Human))
Astrazeneca R & D Lund

Curated by ChEMBL
LigandPNGBDBM50196110(CHEMBL217665 | GNF-PF-2857 | N-(4-(4-methylpiperaz...)
Affinity DataIC50: >2.00E+5nMAssay Description:Inhibition of MK2 assessed as inhibition of [33P]ATP incorporation in to substrate after 30 mins by scintillation countingMore data for this Ligand-Target Pair
In DepthDetails ArticlePubMed